Biobanking Market by Product (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), by Application Regenerative Medicine, Life Sciences, Clinical Research) and Region, Global trends and forecast from 2023 to 2030.

Published on: Nov 2023
From:USD $3499.00
Number Of Pages:124

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 48.33 billion by 2030	7.9%	North America

by Product	by Sample Type	by Application
Equipment Consumables Services Software	Blood Products Human Tissues Cell Lines Nucleic Acids	Regenerative Medicine Life Science Clinical Research

5/5 - (16 votes)

Biobanking Market Overview

The Biobanking market is expected to grow at 7.9% CAGR from 2023 to 2030. It is expected to reach above USD 48.33 billion by 2030 from USD 28.80 billion in 2023.

The process of collecting, preserving, and managing biological samples and associated data for use in research and therapeutic applications is referred to as biobanking. Biobanks can gather a variety of samples, such as blood, tissues, and bodily fluids, as well as clinical data, such as medical histories and lifestyle data. These samples and data are often preserved in biobanks, which are specialized facilities.

Biobanks are increasingly being used in biomedical research and personalized treatment. Biobanks provide researchers with access to large, diverse collections of biological samples and data, which can aid in the discovery of biomarkers for disease detection and diagnosis, the development of personalized treatments based on an individual’s genetic makeup, and the advancement of precision medicine. Biobanking also poses ethical and legal problems about sample collection, storage, and usage, such as donor privacy and the requirement for informed permission.

Biobanking Market | Exactitude Consultancy

The growing desire for personalised treatment is one of the primary drivers of biobanking. With an increased understanding of individual differences in genetics, lifestyle, and environmental variables, personalised medicine is becoming increasingly crucial for illness prevention and treatment. Biobanks are an important source of data and biological samples for the development of personalised medicine, and demand for biobanking services is projected to increase in the future years.

The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is another driver of the biobanking business. These diseases place a considerable burden on healthcare systems globally, and their prevalence is anticipated to rise in the coming years as populations age and lifestyles change. Researchers can use biobanks to examine the underlying causes of various disorders, uncover biomarkers for early detection and diagnosis, and develop new treatments.

The expense of collecting, storing, and managing biological samples and data is one possible market barrier for biobanking. Biobanks necessitate large expenditures in infrastructure, equipment, and employees, which might be prohibitively expensive for smaller organizations or research institutes with limited resources. Furthermore, ethical and legal problems about privacy, ownership, and consent may complicate the process of obtaining and using biological samples for research purposes.

The high cost of adopting and maintaining these systems is a major limitation in the Biobanking business. The initial investment in technology and software can be substantial, particularly for smaller healthcare facilities. Furthermore, the complexity of these systems can result in increased training costs and potential user adoption concerns. Concerns about regulatory and data privacy can also be a problem, especially with the rising usage of cloud-based solutions and the need to comply with various data protection standards.

The COVID-19 pandemic has had an impact on the biobanking sector, both positively and negatively. On the one hand, the pandemic has boosted the focus on vaccine and treatment research and development, raising demand for biobanking services and samples. On the other side, supply chain interruptions, restrictions on research efforts, and budget cuts have all had a detrimental impact on the market. In reaction to the epidemic, there has also been a shift towards virtual biobanking systems, as well as a greater emphasis on data management and sharing.

ATTRIBUTE	DETAILS
Study period	2020-2030
Base year	2022
Estimated year	2023
Forecasted year	2023-2030
Historical period	2019-2021
Unit	Value (USD Billion)
Segmentation	By Product, By Sample Type, By Application, By Region
By Product	Equipment Consumables Services Software
By Sample Type	Blood Products Human Tissues Cell Lines Nucleic Acids
By Application	Regenerative Medicine Life Science Clinical Research
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

Biobanking Market Segment Analysis

The biobanking market is segmented based on product, sample type, application, and region.

Based on product, the biobanking market can be segmented based on equipment, consumables, services, and software. The equipment segment includes freezers, storage systems, and sample management systems. The consumables segment includes storage tubes, sample containers, and other consumables. The services segment includes biorepository, sample processing, and storage services. The software segment includes data management and inventory management software.

Based on sample type, the biobanking market can be segmented based on the type of biological samples stored, including blood products, human tissues, cell lines, and nucleic acids. Blood products segment holds the largest market share due to the rising demand for blood and blood-based products for research and therapeutic purposes. The human tissues segment is expected to grow rapidly due to increased focus on personalized medicine.

Based on application, the biobanking market can be segmented based on its applications, including clinical research, regenerative medicine, drug discovery, and bioburden testing. Clinical research is the largest application segment, followed by regenerative medicine. The drug discovery segment is expected to show the fastest growth due to the increasing demand for personalized medicine

Biobanking Market Players

The biobanking market key market players are Thermo Fisher Scientific, Qiagen, Hamilton Company, Brooks Life Sciences, Tecan Group, VWR International, Promega Corporation, Chart Industries, Bio Life Solutions, Panasonic Healthcare Holdings, Micronics.

Industry Development

24-April -2023: – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced on a specific date in the past that its QIAstat-Dx syndromic testing solution was expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory Panel that could detect more than 20 pathogens from a single patient sample.
05-Januray-2023: – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced an exclusive strategic partnership with California-based population genomics leader Helix to advance companion diagnostics for hereditary diseases in the past..

Who Should Buy? Or Key stakeholders

Researchers
Government
Medical Professionals
Medical Instruments
Clinical Laboratories
Clinics
Others

Biobanking Market Regional Analysis

The biobanking market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

The North America region dominated the biobanking by accounting for over 47% of the market share. The biobanking market in North America is expected to grow significantly in the coming years due to increasing investment in research and development activities, advancements in personalized medicine, and rising demand for high-quality biological samples. The United States dominates the market due to its well-established healthcare infrastructure, favorable regulatory policies, and high healthcare spending. Key players in the North American biobanking market include Thermo Fisher Scientific, Qiagen, Incision, and Hamilton Company, among others.

The biobanking market in Europe is projected to grow at a compound annual growth rate of 7.4% from 2023 to 2030. This growth is driven by the increasing demand for personalized medicine, advancements in biobanking technology, and the rising prevalence of chronic diseases. The UK, Germany, and France are the leading countries in the European biobanking market.

Key Market Segments: Biobanking market

Biobanking by Product, 2020-2030, (USD Billion)

Equipment
Consumables
Services
Software

Biobanking by Sample Type, 2020-2030, (USD Billion)

Blood Products
Human Tissues
Cell Lines
Nucleic Acids

Biobanking by Application, 2020-2030, (USD Billion)

Regenerative Medicine
Life Science
Clinical Research

Biobanking by Region, 2020-2030, (USD Billion)

North America
Asia Pacific
Europe
South America
Middle East and Africa

Important Countries in All Regions Are Covered.

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the biobanking market over the next 7 years?
Who are the major players in the biobanking market and what is their market share?
What are the application industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, And Africa?
How is the economic environment affecting the biobanking market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the biobanking market?
What is the current and forecasted size and growth rate of the global biobanking market?
What are the key drivers of growth in the biobanking market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the biobanking market?
What are the technological advancements and innovations in the biobanking market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the biobanking market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the biobanking market?
What are the service offerings and specifications of leading players in the market?
What is the pricing trend of biobanking market in the market and what is the impact of raw process prices on the price trend?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL BIOBANKING OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON BIOBANKING MARKET
3. PORTER’S FIVE FORCES SAMPLE TYPEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030
1. EQIPMENT
2. CONSUMABLES
3. SERVICES
4. SOFTWARE
GLOBAL BIOBANKING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2030
1. BLOOD PRODUCTS
2. HUMAN TISSUES
3. CELL LINES
4. NUCLEIC ACIDS
GLOBAL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030
1. REGENERATIVE MEDICINE
2. LIFE SCIENCE
3. CLINICAL RESEARCH
GLOBAL BIOBANKING MARKET BY REGION (USD BILLION) 2020-2030
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES*

(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

THERMO FISHER SCIENTIFIC
QIAGEN
HAMILTON COMPANY
BROOKS LIFE SCIENCES
TECAN GROUP
VWR INTERNATIONAL
PROMEGA CORPORATION
CHART INDUSTRIES
BIO LIFE SOLUTIONS
PANASONIC HEALTHCARE HOLDINGS
MICRONICS

*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 2 GLOBAL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 3 GLOBAL BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 4 GLOBAL BIOBANKING MARKET BY REGION (USD BILLION) 2020-2030

TABLE 5 NORTH AMERICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 6 NORTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 7 NORTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 8 NORTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 9 US BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 10 US BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 11 US BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 12 CANADA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 13 CANADA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 14 CANADA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 15 MEXICO BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 16 MEXICO BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 17 MEXICO BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 18 SOUTH AMERICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 19 SOUTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 20 SOUTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 21 SOUTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 22 BRAZIL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 23 BRAZIL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 24 BRAZIL BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 25 ARGENTINA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 26 ARGENTINA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 27 ARGENTINA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 28 COLOMBIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 29 COLOMBIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 30 COLOMBIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 31 REST OF SOUTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 32 REST OF SOUTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 33 REST OF SOUTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 34 ASIA-PACIFIC BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 35 ASIA-PACIFIC BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 36 ASIA-PACIFIC BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 37 ASIA-PACIFIC BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 38 INDIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 39 INDIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 40 INDIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 41 CHINA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 42 CHINA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 43 CHINA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 44 JAPAN BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 45 JAPAN BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 46 JAPAN BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 47 SOUTH KOREA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 48 SOUTH KOREA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 49 SOUTH KOREA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 50 AUSTRALIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 51 AUSTRALIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 52 AUSTRALIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 53 SOUTH-EAST ASIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 54 SOUTH-EAST ASIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 55 SOUTH-EAST ASIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 56 REST OF ASIA PACIFIC BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 57 REST OF ASIA PACIFIC BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 58 REST OF ASIA PACIFIC BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 59 EUROPE BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 60 EUROPE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 61 EUROPE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 62 EUROPE C BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 63 GERMANY BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 64 GERMANY BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 65 GERMANY BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 66 UK BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 67 UK BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 68 UK BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 69 FRANCE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 70 FRANCE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 71 FRANCE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 72 ITALY BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 73 ITALY BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 74 ITALY BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 75 SPAIN BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 76 SPAIN BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 77 SPAIN BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 78 RUSSIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 79 RUSSIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 80 RUSSIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 81 REST OF EUROPE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 82 REST OF EUROPE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 83 REST OF EUROPE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 84 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 85 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 86 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 87 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 88 UAE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 89 UAE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 90 UAE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 91 SAUDI ARABIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 92 SAUDI ARABIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 93 SAUDI ARABIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 94 SOUTH AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 95 SOUTH AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 96 SOUTH AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 97 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 98 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 99 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL BIOBANKING BY PRODUCT, USD BILLION, 2020-2030

FIGURE 9 GLOBAL BIOBANKING BY CELL TYPE, USD BILLION, 2020-2030

FIGURE 10 GLOBAL BIOBANKING BY END-USER, USD BILLION, 2020-2030

FIGURE 11 GLOBAL BIOBANKING BY REGION, USD BILLION, 2020-2030

FIGURE 12 GLOBAL BIOBANKING BY PRODUCT, USD BILLION, 2022

FIGURE 13 GLOBAL BIOBANKING BY CELL TYPE, USD BILLION, 2022

FIGURE 14 GLOBAL BIOBANKING BY END-USER, USD BILLION, 2022

FIGURE 15 GLOBAL BIOBANKING BY REGION, USD BILLION, 2022

FIGURE 16 PORTER’S FIVE FORCES SMAPLE TYPEL

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 19 QIAGEN: COMPANY SNAPSHOT

FIGURE 20 HAMILTON COMPANY: COMPANY SNAPSHOT

FIGURE 21 BROOKS LIFE SCIENCES: COMPANY SNAPSHOT

FIGURE 22 TECAN GROUP: COMPANY SNAPSHOT

FIGURE 23 VWR INTERNATIONAL: COMPANY SNAPSHOT

FIGURE 24 PROMEGA CORPORATION: COMPANY SNAPSHOT

FIGURE 25 CHART INDUSTRIES: COMPANY SNAPSHOT

FIGURE 26 BIO LIFE SOLUTIONS: COMPANY SNAPSHOT

FIGURE 27 PANASONIC HEALTHCARE HOLDINGS: COMPANY SNAPSHOT

FIGURE 28 MICRONICS: COMPANY SNAPSHOT

• What is the worth of medical biobanking market?

The biobanking is expected to grow at 7.9% CAGR from 2023 to 2030. It is expected to reach above USD 44.6 billion by 2029 from USD 22.5 billion in 2020.

• What is the size of the north america medical biobanking market industry?

North America held more than 47% of the biobanking revenue share in 2022 and will witness expansion in the forecast period.

• What are some of the biobanking market's driving forces?

• Which are the top companies to hold the market share in medical biobanking market?

• What is the leading product of biobanking market?

• Which is the largest regional market for biobanking market?

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT